239 related articles for article (PubMed ID: 3343376)
1. Retrospective study of prognostic importance of DNA flow cytometry of urinary bladder carcinoma.
Blomjous CE; Schipper NW; Baak JP; van Galen EM; de Voogt HJ; Meyer CJ
J Clin Pathol; 1988 Jan; 41(1):21-5. PubMed ID: 3343376
[TBL] [Abstract][Full Text] [Related]
2. Flow cytometric analysis of DNA content in human bladder tumors and irrigation fluids.
Chin JL; Huben RP; Nava E; Rustum YM; Greco JM; Pontes JE; Frankfurt OS
Cancer; 1985 Oct; 56(7):1677-81. PubMed ID: 4027899
[TBL] [Abstract][Full Text] [Related]
3. [The DNA content of bladder carcinoma in relation to pathologic grading, staging and prognosis: a flow cytometric study].
Xue J
Zhonghua Wai Ke Za Zhi; 1989 Nov; 27(11):650-3, 700. PubMed ID: 2632194
[TBL] [Abstract][Full Text] [Related]
4. The value of morphometry and DNA flow cytometry in addition to classic prognosticators in superficial urinary bladder carcinoma.
Blomjous EC; Schipper NW; Baak JP; Vos W; De Voogt HJ; Meijer CJ
Am J Clin Pathol; 1989 Mar; 91(3):243-8. PubMed ID: 2923091
[TBL] [Abstract][Full Text] [Related]
5. Characterization of bladder carcinomas by flow DNA analysis.
Gustafson H; Tribukait B
Eur Urol; 1985; 11(6):410-7. PubMed ID: 4085533
[TBL] [Abstract][Full Text] [Related]
6. DNA ploidy as a prognostic factor in muscle invasive transitional cell carcinoma of the bladder.
Deliveliotis C; Georgoulakis J; Skolarikos A; Trakas N; Varkarakis J; Albanis S; Protogerou B; Bamias A
Urol Res; 2005 Feb; 33(1):39-43. PubMed ID: 15258707
[TBL] [Abstract][Full Text] [Related]
7. Prognosis of transitional cell bladder carcinoma. With special reference to ABH blood group isoantigen expression and DNA analysis.
Malmström PU
Scand J Urol Nephrol Suppl; 1988; 112():1-55. PubMed ID: 3068792
[TBL] [Abstract][Full Text] [Related]
8. [Prognostic value of cytofluorometry in bladder tumors].
Verine JL; Coic H; Bertrand G; Lépinard V; Soret JY
Ann Urol (Paris); 1986; 20(3):175-85. PubMed ID: 3729300
[TBL] [Abstract][Full Text] [Related]
9. Cytomorphometric and flow cytometric analysis of bladder transitional cell carcinoma using acridine orange fluorochrome: correlation with histopathology and clinical behavior.
Yu DS; Hsu CM; Chang SY; Ma CP
J Formos Med Assoc; 1992 Feb; 91(2):152-8. PubMed ID: 1364210
[TBL] [Abstract][Full Text] [Related]
10. [DNA profile, recurrence rate and progression of superficial G2 cancer of the urinary bladder].
Maier G; Heissler HE; Blech M; Schröter W
Urologe A; 1988 May; 27(3):173-6. PubMed ID: 3407050
[TBL] [Abstract][Full Text] [Related]
11. Flow cytometric analysis of DNA content of deparaffinized nuclei in urinary bladder carcinomas. Comparison of different isolation methods and relation to histological grade and stage.
Malmström PU; Vasko J; Wester K; Norlén BJ; Busch C
APMIS; 1989 Sep; 97(9):811-9. PubMed ID: 2506919
[TBL] [Abstract][Full Text] [Related]
12. Deoxyribonucleic acid content and survival rates of patients with transitional cell carcinoma of the bladder.
al-Abadi H; Nagel R
J Urol; 1994 Jan; 151(1):37-42. PubMed ID: 8254829
[TBL] [Abstract][Full Text] [Related]
13. Flow cytometric analysis of primary and metastatic bladder cancer.
Badalament RA; O'Toole RV; Keyhani-Rofagha S; Barkley C; Kenworthy P; Accetta P; Wise H; Perez JF; Drago JR
J Urol; 1990 May; 143(5):912-5; discussion 915-6. PubMed ID: 2329605
[TBL] [Abstract][Full Text] [Related]
14. DNA flow cytometry and 67Ki proliferating index as prognostic factors of early recurrence and progression in G1-G2/Ta-T1 and G3/Ta-T1 transitional cell carcinoma of the bladder.
Tizzani A; Casetta G; Gontero P; Giammò A; Ghabin H; Demurtas S; Pacchioni D
Minerva Urol Nefrol; 1997 Sep; 49(3):141-3. PubMed ID: 9396221
[TBL] [Abstract][Full Text] [Related]
15. Deoxyribonucleic acid ploidy and the clinical pattern of grade 2 superficial bladder cancer.
Neulander E; Kaneti J; Chaimovitz C; Sion-Vardy N; Douvdevani A
J Urol; 1997 Apr; 157(4):1254-8; discussion 1258-9. PubMed ID: 9120914
[TBL] [Abstract][Full Text] [Related]
16. [Prognostic significance of DNA content in transitional cell carcinoma of the urinary bladder].
Sun X
Zhonghua Zhong Liu Za Zhi; 1992 Jan; 14(1):24-6. PubMed ID: 1396041
[TBL] [Abstract][Full Text] [Related]
17. Cellular DNA content and proliferative activity evaluated by flow cytometry versus histopathological and staging classifications in human bladder tumors.
de Vita R; Forte D; Maggi F; Eleuteri P; Di Silverio F
Eur Urol; 1991; 19(1):65-73. PubMed ID: 2007422
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of overexpression of p53 tumor suppressor protein in superficial and invasive transitional cell bladder cancer: comparison with DNA ploidy.
Nakopoulou L; Constantinides C; Papandropoulos J; Theodoropoulos G; Tzonou A; Giannopoulos A; Zervas A; Dimopoulos C
Urology; 1995 Sep; 46(3):334-40. PubMed ID: 7660508
[TBL] [Abstract][Full Text] [Related]
19. DNA profile and tumour progression in patients with superficial bladder tumours.
Gustafson H; Tribukait B; Esposti PL
Urol Res; 1982 Feb; 10(1):13-8. PubMed ID: 7072022
[TBL] [Abstract][Full Text] [Related]
20. Biological characterisation of superficial bladder cancer by bivariate cytokeratin 7/DNA analysis, flow cytometric assessment of MIB- 1, and an immunohistochemical study.
Leonardi E; Dalla Palma P; Reich A; Caffo O; Luciani L
Anal Cell Pathol; 2000; 21(1):21-33. PubMed ID: 11254222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]